CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in CollPlant Biotechnologies Ltd as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −5 vs. Q4 2021
- Shares held
- 1.72M
- −83.3K (−4.6%) vs. Q4 2021
- Total value
- $19.5M
- −$10.0M (−34.1%) vs. Q4 2021
- New holders
- 2
- 6 more added
- Sold out
- 7
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $582.4K |
| Q1 2026 | 21 | $819.0K |
| Q4 2025 | 17 | $1.93M |
| Q3 2025 | 19 | $4.08M |
| Q2 2025 | 18 | $2.53M |
| Q1 2025 | 16 | $3.33M |
| Q4 2024 | 14 | $4.59M |
| Q3 2024 | 13 | $6.79M |
| Q2 2024 | 16 | $7.39M |
| Q1 2024 | 13 | $7.59M |
| Q4 2023 | 17 | $9.14M |
| Q3 2023 | 18 | $8.55M |
| Q2 2023 | 17 | $12.5M |
| Q1 2023 | 18 | $10.9M |
| Q4 2022 | 18 | $13.1M |
| Q3 2022 | 21 | $10.7M |
| Q2 2022 | 20 | $14.3M |
| Q1 2022 | 16 | $19.5M |
| Q4 2021 | 21 | $29.5M |
| Q3 2021 | 15 | $33.1M |
| Q2 2021 | 16 | $51.9M |
| Q1 2021 | 15 | $24.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding CollPlant Biotechnologies Ltd; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Roumell Asset Management, LLC | 597,662 | $6.84M | 11.05% | +101,978+20.6% | Added |
| Investment Management of Virginia LLC | 444,444 | $4.99M | 0.88% | −171,110−27.8% | Reduced |
| Villere St Denis J & Co LLC | 265,997 | $2.98M | 0.18% | +9,125+3.6% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 228,657 | $2.57M | 0.01% | +63,203+38.2% | Added |
| Brown Advisory Inc | 77,349 | $868.0K | 0.00% | +15,999+26.1% | Added |
| Benjamin F. Edwards & Company, Inc. | 75,270 | $861.0K | 0.04% | +16,576+28.2% | Added |
| Parallel Advisors, LLC | 16,382 | $192.0K | 0.01% | −3,684−18.4% | Reduced |
| FNY Investment Advisers, LLC | 5,000 | $57.0K | 0.05% | +3,000+150.0% | Added |
| The PNC Financial Services Group, Inc. | 3,600 | $40.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,429 | $38.0K | 0.00% | −1,837−34.9% | Reduced |
| Simplex Trading, LLC | 825 | $9.00K | 0.00% | −781−48.6% | Reduced |
| Geneos Wealth Management Inc. | 750 | $8.00K | 0.00% | +750 | New |
| Morgan Stanley | 250 | $3.00K | 0.00% | −471−65.3% | Reduced |
| Advisor Group Holdings, Inc. | 248 | $3.00K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 100 | $1.00K | 0.00% | +100 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −24,623−100.0% | Sold out |
| Weil Company, Inc. | 0 | $0 | 0.00% | −21,210−100.0% | Sold out |
| Kingsview Wealth Management, LLC | 0 | $0 | 0.00% | −18,415−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −14,770−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,531−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −13,070−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,578−100.0% | Sold out |